Ticagrelor vs. Tirofiban, Comparison of Anti-platelet Effects in Patients With Non-ST Elevation Acute Coronary Syndrome (TE-CLOT Trial : Ticagrelor's Effect for CLOT Prevention) ; A Single Center, Open-label Randomized Controlled Study

Trial Profile

Ticagrelor vs. Tirofiban, Comparison of Anti-platelet Effects in Patients With Non-ST Elevation Acute Coronary Syndrome (TE-CLOT Trial : Ticagrelor's Effect for CLOT Prevention) ; A Single Center, Open-label Randomized Controlled Study

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin; Tirofiban
  • Indications Acute coronary syndromes; Embolism and thrombosis
  • Focus Pharmacodynamics; Registrational
  • Acronyms TE-CLOT
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Nov 2015 Results published in the Thrombosis and Haemostasis
    • 31 Mar 2014 Primary endpoint 'Platelet-aggregation' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top